The PADO Artificial Intelligence team participated in the ESMO AI & Digital Oncology Congress 2026, held in Berlin from 16 to 18 November. The congress, organised by the European Society for Medical Oncology (ESMO), brought together international experts to discuss the role of artificial intelligence in the digital transformation of oncology.
The second edition addressed topics such as the discovery of new biomarkers and the application of language models in clinical practice. Particular attention should be drawn to the participation of Dr Víctor Moreno, Head of PADO, and his AI team, who presented two scientific posters.
The first poster, presented by Fernando Gastón, a researcher in the group, is part of the Tangerine project and explores the use of foundation models such as CONCH and TITAN to identify biomarkers that could help predict responses to immunotherapy.
The second poster, presented by Dr Víctor Moreno, focuses on colorectal cancer and explores the use of the UNI2 foundation model to predict survival based on pathology images. This work aims to improve the prognostic information available beyond conventional clinical and pathological criteria.
Through this participation, PADO strengthens its international presence and contributes to the development of new applications of AI in oncology.

.jpg)

